Systemic vasculitides

Best Practice and Research: Clinical Rheumatology

Volumn 16, Issue 5, 2002, Pages 833-845

  González Gay, Miguel A ^a   García Porrúa, Carlos ^a  

^a HOSPITAL XERAL CALDE   (Spain)

Author keywords

Classification criteria; Environmental; Incidence; Prevalence; Systemic vasculities

Indexed keywords

ARGININE; GLYCINE; HLA DR ANTIGEN; IMMUNOGLOBULIN A; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LYSINE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ALLELE; ALLERGIC VASCULITIS; AMINO ACID SUBSTITUTION; ANAPHYLACTOID PURPURA; AORTA ARCH SYNDROME; ARTERY; BLOOD VESSEL; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; ELDERLY CARE; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; GIANT CELL ARTERITIS; GLOMERULONEPHRITIS; HEREDITY; HUMAN; INCIDENCE; LEUKOCYTOCLASTIC VASCULITIS; NECROSIS; PARVOVIRUS; PATHOGENESIS; POLYARTERITIS NODOSA; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RURAL AREA; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS; URBAN AREA; URBAN RURAL DIFFERENCE; VASCULITIS; WEGENER GRANULOMATOSIS; VASCULAR NECROSIS;

EID: 0036453703     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2002.0260     Document Type: Article

References (50)

1. González-Gay MA & García-Porrúa C. Epidemiology of the vasculitides. Rheumatic Disease Clinics of North America 2001; 27: 729-749.
2. Harper L & Savage CO. Leukocyte-endothelial interactions in antineutrophil cytoplasmic antibody-associated systemic vasculitis. Rheumatic Disease Clinics of North America 2001; 27: 887-903.
3. González-Gay MA, Garciá-Porrúa C, Salvarani C & Hunder GG. Cutaneous vasculitis and cancer: A clinical approach. Clinical and Experimental Rheumatology 2000; 18: 305-307.
4. Hoffman GS. Classification of the systemic vasculitis: Antineutrophil cytoplasmic antibodies, consensus and controversy. Clinical and Experimental Rheumatology 1998; 16: 111-115.
5. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis and Rheumatism 1990 33: 1065-1067.
6. Rao JK, Allen NB & Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Annals of Internal Medicine 1998; 129: 345-352.
7. Michel BA, Hunder GG, Bloch DA & Calabrese LH. Hypersensitivity vasculitis and Henoch-Schönlein purpura: A comparison between the 2 disorders. Journal of Rheumatology 1992; 19: 721-728.
8. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitis. Proposal of an international consensus conference. Arthritis and Rheumatism 1994; 37: 187-192.
9. Watts RA, Jolliffe VA, Carruthers DM et al. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. Arthritis and Rheumatism 1996; 39: 1208-1212.
10. Sorensen SF, Slot O, Tvede N & Petersen J. A prospective study of vasculitis patients collected in a five year period evaluation of the Chapel Hill nomenclature. Annals of the Rheumatic Diseases 2000; 59: 478-482.
11. Watts RA, Lane SE, Bentham G & Scott DG. Epidemiology of systemic vasculitis: A ten-year study in the United Kingdom. Arthritis and Rheumatism 2000; 43: 414-419.
12. Liu NH, LaBree LD, Feldon SE & Rao NA. The epidemiology of giant cell arteritis: A 12-year retrospective study. Ophthalmology 2001; 108: 1145-1149.
13. Petursdottir V, Johansson H, Nordborg E & Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: Special reference to cyclic fluctuations. Rheumatology (Oxford) 1999; 38: 1208-1212.
14. Gran JT & Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: A prospective study 1987-1994. Journal of Rheumatology 1997; 24: 1739-1743.
15. Haugeberg G, Paulsen PQ & Bie RB. Temporal arteritis in Vest Agder county in southern Norway: Incidence and clinical findings. Journal of Rheumatology 2000; 27: 2624-2627.
16. Salvarani C, Gabriel SE, O'Fallon WM & Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: Apparent fluctuations in a cyclic pattern. Annals of Internal Medicine 1995; 123: 192-194.
17. González-Gay MA, García-Porrúa C, Rivas MJ et al. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: Trend over an 18 year period. Annals of the Rheumatic Diseases 2001; 60: 367-371.
18. González-Gay MA, Blanco R, Sanchez-Andrade A & Vazquez-Caruncho M. Giant cell arteritis in Lugo, Spain: A more frequent disease with fewer classic features. Journal of Rheumatology 1997; 24: 2166-2170.
19. Nesher G, Gur H, Ehrenfeld M et al. The changing clinical presentation of temporal arteritis in Israel: A multicenter study. Israel Medical Association Journal 1999; 1: 17-19.
20. Kerr GS. Takayasu's arteritis. Rheumatic Disease Clinics of North America 1995; 21: 1041-1058.
21. Koide K. Takayasu arteritis in Japan. Heart Vessels 1992; 7 (Supplement): 48-54.
22. Watts RA, Carruthers DM & Scott DGI. Epidemiology of systemic vasculitis: Changing incidence or definition? Seminars in Arthritis and Rheumatism 1995; 25: 28-34.
23. González-Gay MA & García-Porrúa C. Systemic vasculitis in the adults in Northwestern Spain, 1988-97. Clinical and epidemiological aspects. Medicine (Baltimore) 1999; 78: 292-308.
24. Watts R, González-Gay MA, Lane SE et al. Geoepidemiology of systemic vasculitis - A comparison of the incidence in two regions of Europe. Annals of the Rheumatic Diseases 2001; 60: 170-172.
25. Watts RA, Lane SE, Scott DG et al. Epidemiology of vasculitis in Europe. Annals of the Rheumatic Diseases 2001; 60: 1156-1157 (Letter).
26. Tidman M, Olander R, Svalander C et al. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: Organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies. Journal of Internal Medicine 1998; 244: 133-141.
27. Abdou NI, Kullman GJ, Hoffman GS et al. Wegener's granulomatosis: Survey of 701 patients in North America. Changes in outcome in 1990s. Journal of Rheumatology 2002; 29: 309-316.
28. Guillevin L, Durand-Gasselin B, Cevallos R et al. Microscopic polyangitis: Clinical and laboratory findings in eighty-five patients. Arthritis and Rheumatism 1999; 42: 421-430.
29. El-Reshaid K, Kapoor MM, El-Reshaid W et al. The spectrum of renal disease associated with microscopic polyangitis and classic polyarteritis nodosa in Kuwait. Nephrology, Dialysis and Transplantation 1997; 12: 1874-1882.
30. Koldingsnes W & Nossent H. Epidemiology of Wegener's granulomatosis in northern Norway. Arthritis and Rheumatism 2000; 43: 2481-2487.
31. Lane SE, Scott DG, Heaton A & Watts RA. Primary renal vasculitis in Norfolk - Increasing incidence or increasing recognition? Nephrology, Dialysis and Transplantation 2000; 15: 23-27.
32. García-Porrúa C, Calviño MC, Llorca J et al. Henoch-Schönlein purpura in children and adults: Clinical differences in a defined population. Seminars in Arthritis and Rheumatism (in press).
33. Calviño MC, Llorca J, García-Porrúa C et al. Henoch-Schonlein purpura in children from northwestern Spain: A 20-year epidemiologic and clinical study. Medicine (Baltimore) 2001; 80: 279-290.
34. Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999; 78: 395-409.
35. García-Porrúa C & González-Gay MA. Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-Schönlein purpura in adults. Seminars in Arthritis and Rheumatism 1999; 28: 404-412.
36. Watts RA, Jolliffe VA, Grattan CE et al. Cutaneous vasculitis in a defined population - Clinical and epidemiological associations. Journal of Rheumatology 1998; 25: 920-924.
37. Reinhold-Keller E, Zeidler A, Gutfleisch J et al. Giant cell arteritis is more prevalent in urban than in rural populations: Results of an epidemiological study of primary systemic vasculitis in Germany. Rheumatology (Oxford) 2000; 39: 1396-1402.
38. Gabriel SE, Espy M, Erdman DD et al. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: A preliminary evaluation. Arthritis and Rheumatism 1999; 42: 1255-1258.
39. Duhaut P, Bosshard S, Calvet A et al. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: A multicenter, prospective case-control study. Grope de Rechercher sur l'Arterite à Cellules Geantes. Journal of Rheumatology 1999; 26: 361-369.
40. Cacoub P, Renou C, Kerr G et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis and Rheumatism 2001; 44: 2118-2124.
41. Duna GF, Cotch MF, Galperin C et al. Wegener's granulomatosis: Role of environmental exposures. Clinical and Experimental Rheumatology 1998; 16: 669-674.
42. Dababneh A, González-Gay MA, García-Porrúa C et al. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. Journal of Rheumatology 1998; 25: 2140-2145.
43. González-Gay MA, García-Porrúa C, Llorca J et al. Visual manifestations of giant cell arteritis: Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000; 79: 283-292.
44. González-Gay MA, García-Porrúa C, Vazquez-Caruncho M et al. The spectrum of polymyalgia rheumatica in northwestern Spain: Incidence and analysis of variables associated with relapse in a 10 year study. Journal of Rheumatology 1999; 26: 1326-1332.
45. Mattey DL, Hajeer AH, Dababneh A et al. Association of giant cell arteritis and polymyalgia rheumatica with different tumor nercrosis factor microsatellite polymorphisms. Arthritis and Rheumatism 2000; 43: 1749-1755.
46. Amoli MM, Thomson W, Hajeer AH et al. HLA-DRBI *01 association with Henoch-Schönlein purpura in patients from northwest Spain. Journal of Rheumatology 2001; 28: 1266-1270.
47. Amoli MM, Thomson W, Hajeer AH et al. Henoch-Schönlein purpura and cutaneous leukocytoclastic angitis exhibit different HLA-DRBI associations. Journal of Rheumatology 2002; 29: 945-947.
48. Amoli MM, Thomson W, Hajeer AH et al. HLA-B*35 association with nephritis in Henoch-Schönlein purpura. Journal of Rheumatology 2002; 29: 948-949.
49. Amoli MM, Mattey DL, Calviño MC et al. Polymorphism at codon 469 of the intercellular adhesion molecule-1 locus is associated with protection against severe gastrointestinal complication in Henoch-Schönlein purpura. Journal of Rheumatology 2001; 28: 1014-1018.
50. Amoli MM, Thomson W, Hajeer AH et al. Interleukin-1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlen purpura. Journal of Rheumatology 2002 (in press).